Discover
Entyvio (vedolizumab) / TakedaNew drug for inflammatory bowel disease in China! Takeda's Entyvio, the world's only intestinal selective biologic, approved! [Google Translation] (Bioon.com) - Mar 15, 2020 - "Takeda China announced recently that Entyvio (Anjiyou®, vedolizumab, vedolizumab for injection)...obtained approval from the National Drug Administration (NMPA) to officially enter China, and was approved for moderate to severe active ulcerative colon with inadequate response, inadequate response, or intolerance to traditional treatment or tumor necrosis factor alpha (TNFα) inhibitors Adults with inflammation and Crohn's disease."
